Repare Therapeutics (RPTX)
(Delayed Data from NSDQ)
$3.59 USD
+0.10 (2.87%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $3.58 -0.01 (-0.28%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (77 out of 250)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.29 | 1.38 | 9.99 |
Current Quarter Estimate | -0.87 | -2.62 | 63.00 |
Year Ago Quarter Estimate | -0.67 | -4.94 | 52.25 |
Next Quarter Estimate | -0.89 | 2.79 | 66.00 |
Next Year Estimate | -3.26 | 21.45 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 3.59 | 16.80 | 15.67 |
Next Year | -51.63 | 9.80 | 11.34 |
Last 5 Years | NA | 4.00 | 8.10 |
Next 5 Years | NA | 21.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -8.36 |
Price/Book (MRQ) | 0.75 | 2.07 |
Price/Cash Flow (MRFY) | NA | 15.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -99.76% | -15.58% |
Return on Equity (TTM) | -38.93% | -14.63% |
Debt to Equity (MRQ) | NA | 4.66 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.